HLA-DRB1 and Pruritus: Few biological markers such as rheumatoid factor (RF) greater than 15 IU/ml at baseline and the presence of an HLA-DRB1*11:01 genotype are emerging as potential predictive biomarkers of skin toxicity, especially in case it is associated with pruritus, in patients treated with ICI-based treatment (85, 86).